The Custom Synthesis and Specialty CDMO industry on FinBizNet covers 13 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 13 |
|---|---|
| Combined market cap | ₹38,918 Cr |
| Median P/E (profitable companies) | 57.7 |
| Median return on equity | 5.6% |
| Companies with latest quarterly results | 9 of 13 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,570 Cr | 79.6 | 5.8% | ₹806 Cr | ₹65 Cr | Q2 FY27 |
| Neogen Chemicals Limited (Neogen) | ₹8,322 Cr | 259.2 | 3.6% | ₹296 Cr | ₹8 Cr | Q2 FY27 |
| Prasol Chemicals Limited | ₹4,681 Cr | 58.1 | — | ₹413 Cr | ₹38 Cr | Q2 FY27 |
| Laxmi Organic Industries Ltd | ₹4,574 Cr | 57.2 | 4.1% | ₹1,083 Cr | ₹57 Cr | Q2 FY27 |
| Tatva Chintan Pharma Chem Ltd | ₹3,871 Cr | 92.5 | 5.5% | ₹217 Cr | ₹21 Cr | Q2 FY27 |
| Paushak Ltd. | ₹1,487 Cr | 38.1 | 8.2% | ₹89 Cr | ₹14 Cr | Q2 FY27 |
| Sunshield Chemicals Ltd. | ₹833 Cr | 25.2 | 17.0% | — | — | — |
| Chemcon Speciality Chemicals Limited | ₹733 Cr | 31.8 | 4.8% | ₹65 Cr | ₹8 Cr | Q2 FY27 |
| Resonance Specialties Ltd. | ₹327 Cr | 31.5 | 15.1% | — | — | — |
| Arvee Laboratories (India) Ltd | ₹251 Cr | 100.0 | 7.8% | ₹25 Cr | ₹3 Cr | Q2 FY27 |
| Dai-Ichi Karkaria Ltd. | ₹223 Cr | — | -0.4% | — | — | — |
| Vadivarhe Speciality Chemicals Ltd | ₹39 Cr | — | -5.0% | — | — | — |
| Omkar Speciality Chemicals Ltd. | ₹7 Cr | — | 7.7% | ₹0 Cr | ₹-1 Cr | Q2 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 13 listed companies in the Custom Synthesis and Specialty CDMO industry, including Anupam Rasayan India Ltd, Neogen Chemicals Limited (Neogen), Prasol Chemicals Limited, Laxmi Organic Industries Ltd, Tatva Chintan Pharma Chem Ltd, Paushak Ltd., Sunshield Chemicals Ltd., Chemcon Speciality Chemicals Limited, among others.
By market capitalisation, the largest Custom Synthesis and Specialty CDMO companies are Anupam Rasayan India Ltd (₹13,570 Cr), Neogen Chemicals Limited (Neogen) (₹8,322 Cr), Prasol Chemicals Limited (₹4,681 Cr), Laxmi Organic Industries Ltd (₹4,574 Cr), Tatva Chintan Pharma Chem Ltd (₹3,871 Cr).
The 13 Custom Synthesis and Specialty CDMO companies tracked on FinBizNet have a combined market capitalisation of about ₹38,918 Cr.
The median price-to-earnings ratio across 10 profitable Custom Synthesis and Specialty CDMO companies is 57.7, and the median return on equity across the industry is 5.6%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Custom Synthesis and Specialty CDMO industry.